Occuity, a Reading-based medtech startup which has developed a patented contactless technology designed to identify early indications of chronic health conditions through optical scans, is seeking to raise £1.8 million through a crowdfunding campaign.

The company, which was founded in 2019, is looking to raise the capital via fundraising platform Seedrs in order to finance the further development of its technology and bring a range of related products to market.

In addition to ophthalmic examinations, Occuity says that the technology can be used for purposes such as diabetes management, screening for pre-diabetes and even to detect early signs of Alzheimer’s disease.

Occuity founder and CEO Dr Dan Daly commented: "The eye provides a window into human health. Occuity's vision is to use this window to identify chronic conditions faster and earlier with non-invasive, non-contact handheld devices, and provide tools to manage those conditions better.”

"There is a huge opportunity to deliver a step-change over the next decade in optometry practice and the way chronic diseases like diabetes and Alzheimer's are detected and managed. We are inviting people who share our vision of transforming health screening to invest in our crowdfunding campaign to improve the lives of hundreds of millions of people worldwide."

Contact us


Tel: +44 (0)1424 777745

Fax: +44 (0)1424 777746



Kirkham Young Ltd.
The Old Court House
North Trade Road
East Sussex
TN33 0EX